| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.9 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.9 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |